Caseware UK (AP4) 2025.0.111 2025.0.111 2025-03-312025-03-312024-04-01false3942falsetruefalse 09186737 2024-04-01 2025-03-31 09186737 2023-04-01 2024-03-31 09186737 2025-03-31 09186737 2024-03-31 09186737 1 2024-04-01 2025-03-31 09186737 d:Director3 2024-04-01 2025-03-31 09186737 c:Buildings 2024-04-01 2025-03-31 09186737 c:Buildings 2025-03-31 09186737 c:Buildings 2024-03-31 09186737 c:Buildings c:OwnedOrFreeholdAssets 2024-04-01 2025-03-31 09186737 c:FurnitureFittings 2024-04-01 2025-03-31 09186737 c:FurnitureFittings 2025-03-31 09186737 c:FurnitureFittings 2024-03-31 09186737 c:FurnitureFittings c:OwnedOrFreeholdAssets 2024-04-01 2025-03-31 09186737 c:OwnedOrFreeholdAssets 2024-04-01 2025-03-31 09186737 c:CurrentFinancialInstruments 2025-03-31 09186737 c:CurrentFinancialInstruments 2024-03-31 09186737 c:Non-currentFinancialInstruments 2025-03-31 09186737 c:Non-currentFinancialInstruments 2024-03-31 09186737 c:CurrentFinancialInstruments c:WithinOneYear 2025-03-31 09186737 c:CurrentFinancialInstruments c:WithinOneYear 2024-03-31 09186737 c:Non-currentFinancialInstruments c:AfterOneYear 2025-03-31 09186737 c:Non-currentFinancialInstruments c:AfterOneYear 2024-03-31 09186737 c:Non-currentFinancialInstruments c:BetweenOneTwoYears 2025-03-31 09186737 c:Non-currentFinancialInstruments c:BetweenOneTwoYears 2024-03-31 09186737 c:ShareCapital 2025-03-31 09186737 c:ShareCapital 2024-03-31 09186737 c:RetainedEarningsAccumulatedLosses 2025-03-31 09186737 c:RetainedEarningsAccumulatedLosses 2024-03-31 09186737 c:FinancialAssetsDesignatedFairValueThroughProfitOrLoss 2025-03-31 09186737 c:FinancialAssetsDesignatedFairValueThroughProfitOrLoss 2024-03-31 09186737 c:AcceleratedTaxDepreciationDeferredTax 2025-03-31 09186737 c:AcceleratedTaxDepreciationDeferredTax 2024-03-31 09186737 d:OrdinaryShareClass1 2024-04-01 2025-03-31 09186737 d:OrdinaryShareClass1 2025-03-31 09186737 d:OrdinaryShareClass1 2024-03-31 09186737 d:FRS102 2024-04-01 2025-03-31 09186737 d:Audited 2024-04-01 2025-03-31 09186737 d:FullAccounts 2024-04-01 2025-03-31 09186737 d:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 09186737 d:SmallCompaniesRegimeForAccounts 2024-04-01 2025-03-31 09186737 e:PoundSterling 2024-04-01 2025-03-31 iso4217:GBP xbrli:shares xbrli:pure

Registered number: 09186737










BROUGHTON HALL CARE LIMITED









FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE YEAR ENDED 31 MARCH 2025

 
BROUGHTON HALL CARE LIMITED
REGISTERED NUMBER: 09186737

BALANCE SHEET
AS AT 31 MARCH 2025

As restated
2025
2024
Note
£
£

Fixed assets
  

Tangible assets
 4 
1,238,355
1,240,546

 
Current assets
  

Debtors: amounts falling due within one year
 5 
631,791
525,596

Cash at bank and in hand
 6 
260,281
121,679

  
892,072
647,275

Creditors: amounts falling due within one year
 7 
(341,079)
(199,002)

Net current assets
  
 
 
550,993
 
 
448,273

Total assets less current liabilities
  
1,789,348
1,688,819

Creditors: amounts falling due after more than one year
 8 
(738,223)
(769,474)

Provisions for liabilities
  

Deferred tax
 11 
(15,609)
(4,252)

  
 
 
(15,609)
 
 
(4,252)

Net assets
  
1,035,516
915,093


Capital and reserves
  

Called up share capital 
  
10,000
10,000

Profit and loss account
  
1,025,516
905,093

  
1,035,516
915,093


The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the statement of comprehensive income in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf by: 


B G Puddle
Director

Date: 17 June 2026

The notes on pages 2 to 10 form part of these financial statements.

Page 1

 
BROUGHTON HALL CARE LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

1.


General information

The Company is a private company limited by shares (registered number 09186737) and registered in England and Wales. The address of the registered office is 2nd Floor, Clifton House, Bunnian Place, Basingstoke, Hampshire, RG21 7JE. The principal place of business is Gatewen Rd, New Broughton, Wrexham, LL11 6YA.

The Company's principal activity during the year under review was that of operating a residential and nursing care home.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the requirements and the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The preparation of financial statements in compliance with FRS 102 requires the use of certain critical accounting estimates. It also requires management to exercise judgment in applying the Company's accounting policies.

These financial statements are presented in Sterling (£) and rounded to the nearest whole(£).

The following principal accounting policies have been applied:

 
2.2

Revenue

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised:

Rendering of services

Revenue from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract when all of the following conditions are satisfied:
the amount of revenue can be measured reliably;
it is probable that the Company will receive the consideration due under the contract;
the stage of completion of the contract at the end of the reporting period can be measured reliably; and
the costs incurred and the costs to complete the contract can be measured reliably.

 
2.3

Finance costs

Finance costs are charged to profit or loss over the term of the debt using the effective interest method so that the amount charged is at a constant rate on the carrying amount. Issue costs are initially recognised as a reduction in the proceeds of the associated capital instrument.

 
2.4

Borrowing costs

All borrowing costs are recognised in profit or loss in the year in which they are incurred.

Page 2

 
BROUGHTON HALL CARE LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

2.Accounting policies (continued)

 
2.5

Pensions

Defined contribution pension plan

The Company operates a defined contribution plan for its employees. A defined contribution plan is a pension plan under which the Company pays fixed contributions into a separate entity. Once the contributions have been paid the Company has no further payment obligations.

The contributions are recognised as an expense in profit or loss when they fall due. Amounts not paid are shown in accruals as a liability in the Balance Sheet. The assets of the plan are held separately from the Company in independently administered funds.

 
2.6

Current and deferred taxation

The tax expense for the year comprises current and deferred tax. Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the balance sheet date in the countries where the Company operates and generates income.

Deferred tax balances are recognised in respect of all timing differences that have originated but not reversed by the balance sheet date, except that:
The recognition of deferred tax assets is limited to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits; and
Any deferred tax balances are reversed if and when all conditions for retaining associated tax allowances have been met.

Deferred tax balances are not recognised in respect of permanent differences except in respect of business combinations, when deferred tax is recognised on the differences between the fair values of assets acquired and the future tax deductions available for them and the differences between the fair values of liabilities acquired and the amount that will be assessed for tax. Deferred tax is determined using tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


 
2.7

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Page 3

 
BROUGHTON HALL CARE LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

2.Accounting policies (continued)


2.7
Tangible fixed assets (continued)

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, using the straight-line method.

Depreciation is provided on the following basis:

Freehold property
-
2%
straight line
Fixtures and fittings
-
25%
straight line

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

 
2.8

Debtors

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

 
2.9

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

 
2.10

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

 
2.11

Provisions for liabilities

Provisions are recognised when an event has taken place that gives rise to a legal or constructive obligation, a transfer of economic benefits is probable and a reliable estimate can be made.

Provisions are measured as the best estimate of the amount required to settle the obligation, taking into account the related risks and uncertainties.
 
Deferred tax liabilities are also presented within provisions but are measured in accordance with the accounting policy on taxation.
 
Increases in provisions are generally charged as an expense to profit or loss.

 
2.12

Financial instruments

The Company has elected to apply the provisions of Section 11 “Basic Financial Instruments” of FRS 102 to all of its financial instruments.

The Company has elected to apply the recognition and measurement provisions of IFRS 9 Financial Instruments (as adopted by the UK Endorsement Board) with the disclosure requirements of Sections 11 and 12 and the other presentation requirements of FRS 102.
Page 4

 
BROUGHTON HALL CARE LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

2.Accounting policies (continued)


2.12
Financial instruments (continued)


Financial instruments are recognised in the Company's Balance Sheet when the Company becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include trade and other debtors, cash and bank balances, are initially measured at their transaction price (adjusted for transaction costs except in the initial measurement of financial assets that are subsequently measured at fair value through profit and loss) and are subsequently carried at their amortised cost using the effective interest method, less any provision for impairment, unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest.

Discounting is omitted where the effect of discounting is immaterial. The Company's cash and cash equivalents, trade and most other debtors due with the operating cycle fall into this category of financial instruments.

Basic financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the Company after the deduction of all its liabilities.

Basic financial liabilities, which include trade and other creditors, bank loans and other loans are initially measured at their transaction price (adjusting for transaction costs except in the initial measurement of financial liabilities that are subsequently measured at fair value through profit and loss). When this constitutes a financing transaction, whereby the debt instrument is measured at the present value of the future payments discounted at a market rate of interest, discounting is omitted where the effect of discounting is immaterial.

Debt instruments are subsequently carried at their amortised cost using the effective interest rate method.

Trade creditors are obligations to pay for goods and services that have been acquired in the ordinary course of business from suppliers. Trade creditors are classified as current liabilities if the payment is due within one year. If not, they represent non-current liabilities. Trade creditors are initially recognised at their transaction price and subsequently are measured at amortised cost using the effective interest method. Discounting is omitted where the effect of discounting is immaterial.


3.


Employees

The average monthly number of employees, including directors, during the year was 39 (2024 - 42).

Page 5

 
BROUGHTON HALL CARE LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

4.


Tangible fixed assets


Freehold property
Fixtures and fittings
Total

£
£
£



Cost or valuation


At 1 April 2024
1,312,398
110,189
1,422,587


Additions
42,699
-
42,699



At 31 March 2025

1,355,097
110,189
1,465,286



Depreciation


At 1 April 2024
119,729
62,312
182,041


Charge for the year on owned assets
44,890
-
44,890



At 31 March 2025

164,619
62,312
226,931



Net book value



At 31 March 2025
1,190,478
47,877
1,238,355



At 31 March 2024
1,192,669
47,877
1,240,546

Page 6

 
BROUGHTON HALL CARE LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

5.


Debtors

As restated
2025
2024
£
£


Trade debtors
77,560
96,021

Amounts owed by group undertakings
541,035
423,282

Other debtors
5,858
-

Prepayments and accrued income
7,338
6,293

631,791
525,596


Amounts owed by group undertakings are interest free, unsecured, and repayable on demand.


6.


Cash and cash equivalents

2025
2024
£
£

Cash at bank and in hand
260,281
121,679



7.


Creditors: Amounts falling due within one year

2025
2024
£
£

Bank loans
44,259
54,800

Trade creditors
14,516
15,117

Amounts owed to group undertakings
160,573
30,229

Corporation tax
33,728
19,788

Other creditors
2,307
1,113

Accruals and deferred income
85,696
77,955

341,079
199,002


Amounts owed to group undertakings are interest free, unsecured, and repayable on demand.

The terms of the bank loans are detailed in note 9.


8.


Creditors: Amounts falling due after more than one year

2025
2024
£
£

Bank loans
738,223
769,474


The terms of the bank loans are detailed in note 9.

Page 7

 
BROUGHTON HALL CARE LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

9.


Loans


Analysis of the maturity of loans is given below:


2025
2024
£
£

Bank loans

Amounts falling due within one year
44,259
54,800

Amounts falling due 2-5 years
738,223
769,474

782,482
824,274


Fixed and floating charges are held by HSBC UK Bank PLC dated 20 March 2019. The final instalment is payable on 15 February 2029. The interest rate is variable and linked to the bank rate.

All bank loans were settled in full in November 2025, See note 15 for further information.


10.


Financial instruments

2025
2024
£
£

Financial assets


Financial assets measured at fair value through profit or loss
260,281
121,679




Financial assets measured at fair value through profit or loss comprise...


11.


Deferred taxation




2025


£






At beginning of year
(4,252)


Charged to profit or loss
(11,357)



At end of year
(15,609)

The provision for deferred taxation is made up as follows:

2025
2024
£
£


Accelerated capital allowances
(15,609)
(4,252)

(15,609)
(4,252)

Page 8

 
BROUGHTON HALL CARE LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

12.


Share capital

2025
2024
£
£
Allotted, called up and fully paid



100 (2024 - 100) Ordinary shares of £100.00 each
10,000
10,000



13.


Prior year adjustment

During the year ended 31 March 2025, the directors identified that revenue recognised in the prior year in respect of invoices subsequently credited post year-end and not re-invoiced should not have been recognised. During the year ended 31 March 2025, the directors also identified that certain trade debtors recognised in the prior year were not recoverable at the reporting date and should have been impaired in accordance with the Company’s accounting policy.
 
This represents the correction of a prior period error under FRS 102. The error has been corrected by restating the comparative amounts for the prior period and adjusting opening retained earnings at 1 April 2024.
 
The impact of the restatement is as follows:
 
- Decrease in revenue at for the year ended 31 March 2024 of £31,332
- Increase in administrative expenses for the year ended 31 March 2024 of £23,938
- Decrease in taxation charge for the year ended 31 March 2024 of £13,818
- Decrease in trade debtors at 31 March 2024 of £55,270
- Decrease in corporation tax payable at 31 March 2024 of £13,818
 
The net effect is a reduction in profit after tax of £41,452 and a corresponding decrease in retained earnings at 1 April 2024.


14.


Pension commitments

The Company operates a defined contributions pension scheme. The assets of the scheme are held separately from those of the Company in an independently administered fund. The pension cost charge represents contributions payable by the Company to the fund and amounted to £15,848 (2024 - £14,333). Contributions totalling £70 (2024 - £70) were payable to the fund at the balance sheet date and are included in creditors.


15.


Related party transactions

The Company is exempt from disclosing related party transactions with other 100% owned members of the Group headed by Select Health Care Limited by virtue of FRS 102 section 33.1A. Amounts due to and from members of the Group are disclosed in note 5 and 7 respectively.


16.


Post balance sheet events

On 25 September 2025, subsequent to the reporting date, the entire issued share capital of the immediate parent company was acquired by Deer Capital Select Elderly Care Limited.

As part of this acquisition, all external bank loans in the Company were repaid in full and new funding has been provided via a sale and leaseback arrangement.

Page 9

 
BROUGHTON HALL CARE LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

17.


Controlling party

The immediate parent company at 31 March 2025 is Select Health Care General Limited, a company incorporated in England and Wales.

The ultimate parent company and the smallest and largest group in which the Company's results are consolidated is Select Health Care Limited, a company incorporated in England and Wales. The consolidated accounts of Select Health Care Limited are available from Companies House, Crown Way, Cardiff, CF14 3UZ.

Following the acquisition detailed in note 15, the ultimate parent company and controlling party is now Deer Capital ESG Investments Europe Limited.


18.


Auditors' information

The auditors' report on the financial statements for the year ended 31 March 2025 was unqualified.

The audit report was signed on 17 June 2026 by Alexander Peal BSc (Hons) FCA DChA (Senior Statutory Auditor) on behalf of James Cowper Kreston Audit.


Page 10